(11bR,11'bR)- 4,4'-[(1S,2S)-1,2-二苯基-1,2-乙二基]-双[4,5-二氢-H-联萘并[2,1-c:1',2'-e]氮杂卓
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea
(11bR)-(-)-4,4-Dibutyl-4,5-dihydro-2,6-bis(3,4,5-trifluorophenyl)-3H-dinaphth[2,1-c:1,2-e ]阿泽匹纽【对照品】887938-70-7
1469882-57-2(标准品)(1R,2R)-2 - [(4S,11bR)-3,5-二氢-4H-萘并[2,1-C:1',2'-E] phosphepin-4-基]-1,2-二苯基乙基胺
1265884-98-7(标准品)5-(11bR)-5H-Dibenz[b,f]azepine-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl, 95%
双(2-[(11BR)-3H-二萘并[2,1-C:1',2'-E]亚磷-4(5H)-基]乙基)胺
Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1)
Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
(11bR,11'bR)-4,4'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis-dinaphtho[2,1-d:1', 2'-f][1,3,2]dioxaphosphepin,349114-63-2
(11bR)-(-)-4,4-Dibutyl-4,5-dihydro-2,6-bis(3,4,5-trifluorophenyl)-3H-dinaphth[2,1-c:1',2'-e]azepinium bromide,887938-70-7
(3R,3Ar,5As,5Br,7As,11As,11Br)-3-Isopropyl-3A,5A,5B,8,8,11A-Hexamethyl-2,3,3A,4,5,5A,5B,6,7,7A,8,9,10,11,11A,11B,12,13-Octadecahydro-1H-Cyclopenta[A]Chrysene
Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea
(2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a,11b-hexadecahydro-3-hydroxy-3',6',10,11b-tetramethyl-Spiro[9H-benzo[a]fluorene-9,2'(3'H
(2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a,11b-hexadecahydro-3-hydroxy-3',6',10,11b-tetramethyl-Spiro[9H-benzo[a]fluorene-9,2'(3'H
(3S,3'S,5aR,5aR,10bR,10'bR,11aS,11'aS)-2,2',3,3',5a,5'a,6,6'-octahydro-3,3'-bis(hydroxymethyl)-2,2'-dimethyl-[10b,10'b(11H,11'H)-bi3,11a-epidithio-11aH-pyrazino[1',2':1,5
2-[(11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]ethyl]amine, min. 97% / 2-[(11bR)-3,5-dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]ethyl]amine, min. 97% ≥97%
2-[(11bR)-3H-Binaphtho[2,1-c:1',2'-e]phosphepin-4(5H)-yl]ethylamine, 97+% / 2-[(11bR)-3H-Binaphtho[2,1-c:1',2'-e]phosphepin-4(5H)-yl]ethylamine, 97+% 1092064-00-0
整合素α2 / 整合素α2抗体
740816-14-2 (5aS,10bR)-2-(全氟.苯基)-4,5a,6,10b-四氢-2H-茚并[2,1-b][1,2,4]三唑并[4,3-d][1,4]恶嗪-11-鎓四氟硼.酸盐
751-03-1 (1S,3aS,4aR,4bR,6aR,11aR,11bR,13aS)-1-(呋喃-3-基)-4b,7,7,11a,13a-五甲基-6,6a,7,11a,11b,12,13,13a-八氢氧杂卓并[4',3':3,4]苯并[1,2-f]环氧.乙烷[2,3-d]异苯并吡喃-3,5,9(1H,3aH,4bH)-三酮
4449-51-8 (2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3',6',10,11b-四甲基-1,2,3,3a',4 ,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-十八氢-3'H-螺[苯并[a]芴-9,2' -呋喃并[3,2-b]吡.啶] -3-醇
(4AR,6AS,11BR,11CS)-1-甲酰基-1,3,4,5,6,11C-六氢-13-氧代-4A,11B-丙桥-2H-吡啶并[3,2-C]咔唑-6A,7-二羧酸二甲酯标准品
1,2,5B(5BR,11BR)-11B-四氢-2-(1-甲基乙烯基)-6H-呋喃并[2’,3’:6,7]苯并呋喃[3,2-C][1]苯并吡喃-9-醇cas:213912-46-0
888482-17-5 (4AR,6AS,11BR,11CS)-1-甲酰基-1,3,4,5,6,11C-六氢-13-氧代-4A,11B-丙桥-2H-吡啶并[3,2-C]咔唑-6A,7-二羧酸二甲酯 11,12-De(methylenedioxy)danuphylline价格
Phenanthro[2,1-f]quinoline-8a(1H)-carboxylic acid, 2,3,4,4a,5,6,6a,6b,7,8,9,10,11,12,12a,14,14a,14b-octadecahydro-6a,6b,11,11,14b-pentamethyl-3-oxo-, methyl ester, (4aR,6aR,6bS,8
Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (1:1)
Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (11bR)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
丁香通为您找到 301 条 c9h11br2n 商家的详情参数,实时报价,价格行情,优质批发/供应等信息。您还可以找 c9h11br2n,绿化工程合同,干细胞激活液 等商家信息。
手机验证
我的询价